With the latest batch’s agreements, only three out of the 17 drugmakers initially targeted by Trump have not signed pricing ...

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

In this interview, Charles Chase, PhD, the VP and Technical Business Development at Asymchem, a technology-focused pharmaceutical manufacturing company, discusses the significant impact of RNA ...

First and Only AI-Simulated Roleplay Solution Exclusively Designed for Pharmaceutical Field Professionals, Awarded for AI ...

This year has seen a rapid rise in the demand for Ozempic due to it being popularised by celebrity endorsements online, leading to a shortage of product. Ozempic is a brand of semaglutide that helps ...

The EU pharmaceutical reform aims to improve drug accessibility, affordability, and innovation, addressing market protection and antimicrobial resistance. Co-legislators in Europe have reached a ...

Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and straining inventories. Companies are reshoring manufacturing to avoid ...

DAVIS, Calif.--(BUSINESS WIRE)--Botanical Solution, a leading producer of advanced botanical materials, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and ...

Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Want to share this FREE webinar with a colleague? Fill out the form below and we'll send your colleague an invitation to the "Enhancing Pharmaceutical Manufacturing Using Raman Spectroscopy" event.

Exports of pharmaceutical technology this year have exceeded KRW 10 trillion, outperforming last year's figure. A report quoting the London-based company Global Data by the Korea Bio-Economic Research ...